Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Drillbits & Bottlerockets -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (14076)	6/6/2001 6:15:30 AM
From: Rich1	Respond to of 15481

Last day of the conference today cant wait to go back to work...LOL Todays IBD Big Picture... The Big Picture Wednesday, June 6, 2001 Printer-Ready Version Indexes Race Ahead In Heavier Volume Investor's Business Daily After almost two weeks of moderate selling and lazy buying, the stock market bolted back to life Tuesday. Techs blazed the trail as investors reconsidered whether profits the rest of the year were a lost cause. Xilinx (XLNX) stood by earlier guidance, which inspired Wall Street after last week’s parade of profit warnings. Business improved in May for the maker of programmable chips as order cancellations slowed. The stock gapped up and rallied 4.02 to 45.61. Xilinx wasn’t the only company seeing better times. Lucent Technologies (LU), usually a bearer of bad news, expects a modest rise in fiscal third-quarter sales compared with its second quarter. The telecom equipment maker picked up 0.49, or 6%, to 8.49. Amazon.com (AMZN) and Pfizer (PFE) also reaffirmed their profit outlooks. Investors didn’t rejoice, though. Both stocks slipped about a half-point. Comverse Technology (CMVT) went a step further and actually reported better-than-expected earnings. Shares of the telecom software company vaulted 8.86 to 67.52 on twice its usual trade. But like a lot of tech stocks, Comverse must fight through loads of disgruntled shareholders before it can even challenge its January high of 124.75. The Nasdaq leapt 3.6% as trading volume swelled 38% to 1.84 billion shares. The rally broke ranks with three straight days of tame gains on declining volume. The session didn’t limit itself to the tech sector. Advances also scored a big lead over declines on the New York Stock Exchange. IBM (IBM), Microsoft (MSFT), 3M (MMM), Alcoa (AA), Johnson & Johnson (JNJ), and Merck (MRK) teamed up to lift the Dow industrial average 1%. The S&P shrugged off weakness in the energy sector to climb 1.3%. NYSE volume also reawakened, charging up 31% to 1.12 billion shares. Medical stocks, now a fixture near the top of the list of 52-Week Highs, delivered strong gains. Idec Pharmaceuticals (IDPH), which carries a 99 Earnings Per Share Rating and an 89 Relative Price Strength Rating, ran up 5.61 to 74. Ivax (IVX) rallied 8.7%, Cima Labs (CIMA) 8.1%, Gentiva Health Services (GTIV) 4.7%, Barr Labs (BRL) 4.5% and Pharmaceutical Product Development (PPDI) 4.3%. Not all sectors had the wind at their backs. Energy producers enjoyed a big run from June to October last year. But on Tuesday, IBD’s Energy-Other group, while still ranked eighth among 197 groups, tottered. Calpine (CPN) fell 2.45 on huge volume to 43.30, slipping below its 200-day moving average for the first time since January. The builder and operator of natural-gas power plants broke out of a base March 20, then got yanked back the next day. It plodded higher the next few weeks and tried to build an extra base on top of its old base. It soon rolled over in the week ended May 25, just as Sen. James Jeffords bolted the Republican Party, possibly putting a dent into President Bush’s plans to expand the energy supply. California’s energy woes aren’t helping either. NRG Energy (NRG) gave up 1.62 to 26.83, sinking further below its 200-day on heavy trade. Its breakout from a six-month base in late March also has fallen apart.

To: Jorj X Mckie who wrote (14076)	6/6/2001 10:16:56 AM
From: faqsnlojiks	Respond to of 15481

just the chart....I found it interesting. I don't know much about the company itself. -Joe